Indeed, in previous studies of NB immunotherapy by anti-CD4+ IL-21, the reconstituted CD4+ T cells were fundamental for rejection of a second tumorigenic challenge of Neuro2a cells21. This evidence concerns the gene IL21 and neuroblastoma.